Sinonasal Sarcomas Management: An International Consensus Statement
International Forum of Allergy & Rhinology · 2026-01 · 16 (1) · 55-69
DOI: 10.1002/alr.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 30.09.2025. Verfasst von Alessandro Vinciguerra und 51 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Lariana, Como, Italy. Hauptthemen laut MEDLINE: Sarcoma, Paranasal Sinus Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Sinonasal sarcomas are exceedingly rare entities, constituting less than 7% of head and neck sarcomas. Their complex histology needs specialized treatment, which is often based on multimodal approaches including surgery, radiation therapy, and/or chemotherapy. This manuscript aims to gather expert opinions to establish common management principles for sinonasal sarcomas.
Methods
This international consensus followed a modified Delphi method in seven steps, including statements definition by the core group, expert panel recruitment, and a two‐round survey. Sixty‐two statements on sinonasal sarcoma management were developed. Experts from multiple continents participated, and results were anonymized and analyzed between March and May 2025.
Results
A total of 44 invited experts were recruited, 43.2% otorhinolaryngologists/head and neck surgeons, 31.8% medical oncologists, and 25% radiation oncologists. Participants varied in age and experience, representing Europe (70.5%), North America (18.2%), South America (6.8%), and Asia (4.5%). Among all histologies, biphenotypic sarcoma, chondrosarcoma, leiomyosarcoma, and myofibrosarcoma are principally treated with an upfront surgical management, differently from Ewing sarcoma and rhabdomyosarcoma in which chemotherapy, eventually associated with radiotherapy, is often chosen. In the remaining histologies (angiosarcoma, liposarcoma, malignant peripheral nerve sheath tumor [MPNST], osteosarcoma, and synovial sarcoma), a precise multimodal treatment is less standardized and needs to be discussed on a case‐by‐case basis.
Conclusion
Sinonasal sarcomas require a histology‐driven approach to determine upfront treatment, whether surgical, medical, or multimodal. Despite this structured strategy, prognosis remains highly variable across subtypes. Multidisciplinary evaluation and individualized management in referral centers are crucial to address the biological diversity and anatomical complexity of these rare malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Lariana, Como, Italy.
- Head and Neck Medical Oncology Department, ASST Lariana, Como, Italy.
- Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
- Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
- Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
- Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Salvatore Provenzano, Eric W Wang, Marco Ferrari, Alberto Schreiber, Matt Lechner, Jean Yves Blay, Christos Georgalas, Mario Turri-Zanoni
Zitieren
APA
Vinciguerra, A., Caspani, F., Valentini, M., Camarda, A. M., Provenzano, S., Wang, E. W., Meço, C., Ferrari, M., Surda, P., Harrabi, S., Campos, F. A. B., Broto, J. M., Guadagnolo, B. A., Navarria, P., Hosni, A., Hindi, N., Italiano, A., Trifiletti, D. M., Kasper, B., …, & Battaglia, P. (2026). Sinonasal Sarcomas Management: An International Consensus Statement. International Forum of Allergy & Rhinology, 16(1), 55-69. https://doi.org/10.1002/alr.70038
Vancouver
Vinciguerra A, Caspani F, Valentini M, Camarda AM, Provenzano S, Wang EW, et al. Sinonasal Sarcomas Management: An International Consensus Statement. International Forum of Allergy & Rhinology. 2026;16(1):55-69. doi:10.1002/alr.70038
BibTeX
@article{Vinciguerra2026,
author = {Vinciguerra, Alessandro and Caspani, Francesca and Valentini, Marco and Camarda, Anna Maria and Provenzano, Salvatore and Wang, Eric W and Meço, Cem and Ferrari, Marco and Surda, Pavol and Harrabi, Semi and Campos, Fernando Augusto Batista and Broto, Javier Martin and Guadagnolo, B Ashleigh and Navarria, Pierina and Hosni, Ali and Hindi, Nadia and Italiano, Antoine and Trifiletti, Daniel M and Kasper, Bernd and Verillaud, Benjamin and Schreiber, Alberto and Castelnuovo, Paolo and Nicolai, Piero and Dallan, Iacopo and Chacon, Matias and Su, Shirley Y and Thariat, Juliette and Valverde, Claudia and Lechner, Matt and Blay, Jean Yves and Fiore, Maria Rosaria and Eloy, Jean Anderson and Brahmi, Mehdi and Palmer, James N and Oliden, Victor Castro and Greto, Daniela and Lugowska, Iwona and Tos, Angelo Paolo Dei and van Zele, Thibaut and Psaltis, Alkis J and Casali, Paolo Giovanni and Dufresne, Armelle and Sangalli, Claudia and Georgalas, Christos and Orlandi, Ester and Wormald, Peter-John and Herman, Philippe and Carrau, Ricardo and Hanna, Ehab Y and Licitra, Lisa and Turri-Zanoni, Mario and Battaglia, Paolo},
title = {Sinonasal Sarcomas Management: An International Consensus Statement},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
volume = {16},
number = {1},
pages = {55--69},
doi = {10.1002/alr.70038}
}
EUVIMED